Dr. Shama Tichkule is an experienced patent professional focused on drafting provisional and non-provisional patent applications in chemistry and pharmaceuticals, as well as, drafting responses to domestic and foreign official actions. She conducts patentability assessments and participates in Examiner interviews.
Before joining the firm, Shama was a licensing associate at the MIT Technology Licensing Office and was involved in managing a large portfolio of organic chemistry, material science, clean water and energy technologies, negotiating and drafting license and joint invention agreements, and managing compliance of existing agreements.
Prior to MIT TLO, Shama was an intern at Partners HealthCare and where she was involved in patentability of the invention based on the statutory principles of novelty and non-obviousness, conducting prior art searches, analyzing infringement opinions and managing research portfolios based on the invention disclosures. She also managed new filings, PCT applications, national stage applications and annuities.
As part of her doctoral research, Shama synthesized more than 80 potent cannabinoid analogues through multi-step synthesis. Shama accomplished a challenging 22 step synthesis of novel hybrid adamantyl tricyclic cannabinoids and developed a more efficient, 13-step route and developed SAR of tricyclic NAH cannabinoids (through 14 synthetic steps).